Atrium Therapeutics shares owned by Grantham, Mayo, Van Otterloo & Co
Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Grantham, Mayo, Van Otterloo & Co
from 13F filings
Historical chart of Grantham, Mayo, Van Otterloo & Co investment in Atrium Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Atrium Therapeutics held by Grantham, Mayo, Van Otterloo & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atrium Therapeutics by Grantham, Mayo, Van Otterloo & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $207k | 15k | 13.37 |
More positions owned by Grantham, Mayo, Van Otterloo & Co
View all positions for Grantham, Mayo, Van Otterloo & Co